Case Summary:

Through the I-907 form, the USCIS has begun allowing premium processing for applications under the EB2-NIW (National Interest Waiver) category from 2023 onwards. So the processing time for an NIW visa has lowered significantly. Our firm has dealt with tens of thousands of cases over the years and the resulting database of knowledge is so immense that it gives us an upper hand over other firms working in the area.

So, when an imaging engineer from China working in electrical engineering visited us for his NIW case, we made certain that his case was well-prepared before applying. Our team dug up details on his academic and professional documents and found the following:

• As an expert in the field, his work is to develop next-generation medical imaging platforms in order to advance cancer diagnosis, prognosis, and drug development for improved patient care and life extension.
• This research is of great importance because it provides next-generation imaging platforms with unprecedented capabilities vis-à-vis the imaging of cancer cells and complexes at super-high resolutions.
• He has dramatically advanced the state of medical imaging technologies, as he has, for example, designed a cutting-edge framework for single particle tracking and the quantification of diffusion behavior, which is essential for understanding the mechanobiological mechanisms involved in cancer onset, development, and metastatic spread across the body.
• His work is also of considerable value to the medical technology industry. He has broken ground in medical imaging technologies, effectively providing this economically important industry with next-generation imaging tools for the study, diagnosis, prognosis, and treatment of cancer and other major human diseases.
• His proposed endeavor also has broad implications for the United States, as the medical device industry is a key component of the United States’ economy.
• He has also developed next-generation medical imaging frameworks for the study, diagnosis, prognosis, and treatment of cancer and other major human diseases, and for drug discovery and development, it is readily apparent that he has promoted innovation in this economically important industry.
• Due to its clear national importance, his work has been supported with funding from the National Institutes of Health and the National Science Foundation and this research has resulted in 8 peer-reviewed journal articles that have been cited a total of 421 times.
• In his 7 years of service to the field, he has gained expertise in the field making him a leading researcher and expert.

Thus, once these factors were weighed by the adjudicating bench, they found the scales in favor of our client who had upgraded his case to premium processing(PP). Only 7 days after the PP upgrade, the approval was obtained.

We are proud to have worked with him on the case and we wish him all the best in his future endeavors in the field.